Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca CIO Makes IT Twice As Good At Half The Cost - Here Is How
Forbes
Tue, 01/3/17 - 11:49 am
Tags:
Dave Smoley, AstraZeneca, IT
Label Expansion May Boost Revenues for AstraZeneca’s Tagrisso
Market Realist
Tue, 01/3/17 - 09:49 am
Tags:
AstraZeneca, Tagrisso, non-small cell lung cancer
AstraZeneca’s Tagrisso Had a Strong Commercial Launch in 2016
Market Realist
Mon, 01/2/17 - 11:57 am
Tags:
AstraZeneca, Tagrisso, non-small cell lung cancer
AstraZeneca Could See Modest Fall in 2016 Revenues
Market Realist
Sun, 01/1/17 - 11:34 am
Tags:
AstraZeneca
PFE Completes Acquisition From AZN (PFE)
Investopedia
Sat, 12/24/16 - 12:15 pm
Tags:
Pfizer, AstraZeneca, Zavicefta
Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca
Yahoo
Fri, 12/23/16 - 10:00 am
Tags:
Pfizer, M&A, AstraZeneca, small molecule drugs, anti-infectives
Ionis Earns $28 Million from AstraZeneca for a New Drug to Treat Cancer
Yahoo
Fri, 12/16/16 - 09:45 am
Tags:
Ionis, AstraZeneca, AZD4785, KRAS, cancer
Your attention, please: AstraZeneca asks for a moment of rapt silence, for a BLA acceptance?
Endpoints
Sun, 12/11/16 - 11:57 am
Tags:
AstraZeneca, durvalumab, anti-PD-L1, bladder cancer
Eli Lilly to pay AstraZeneca $30 million as part of a collaboration on an Alzheimer's treatment
Marketwatch
Fri, 12/9/16 - 09:49 am
Tags:
Eli Lilly, AstraZeneca, Alzheimer's disease
AstraZeneca cutting 700 U.S jobs, 120 in Phila. region
Bizjournals.com
Thu, 12/8/16 - 11:32 pm
Tags:
AstraZeneca, layoffs
AstraZeneca gives fuller picture of Tagrisso's edge in lung cancer
BioPharma Dive
Tue, 12/6/16 - 10:02 pm
Tags:
AstraZeneca, Tagrisso, non-small cell lung cancer
Star-crossed AstraZeneca strikes a drug discovery deal with upstart Bicycle
Endpoints
Thu, 12/1/16 - 10:24 am
Tags:
AstraZeneca, drug discovery, Bicycle Therapeutics
AstraZeneca spins out a bispecific antibody into a new cancer biotech with partner AbPro
Endpoints
Tue, 11/29/16 - 09:51 am
Tags:
AstraZeneca, bispecific antibodies, MedImmune, AbPro, cancer
Rest easy, pharma. AstraZeneca, Ranbaxy prevailed in landmark pay-for-delay case
Fierce Pharma
Wed, 11/23/16 - 10:23 am
Tags:
pay-for-delay, AstraZeneca, Ranbaxy, Nexium
$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market
Motley Fool
Mon, 11/21/16 - 02:35 pm
Tags:
Alzheimer's disease, AstraZeneca, Biogen, Eli Lilly, Merck, Roche, BACE inhibitors
Brace Yourself: AstraZeneca Could Be a Fourth Entrant into the PD-1/PD-L1 Drug Class
Market Realist
Mon, 11/21/16 - 11:39 am
Tags:
AstraZeneca, anti-PD-L1, durvalumab, Opdivo, Keytruda, Tecentriq, Bristol-Myers Squibb, Roche, Merck
Pfizer, AstraZeneca outpace Big Pharma in emerging markets as growth ticks upward
Fierce Pharma
Fri, 11/18/16 - 10:09 am
Tags:
Pfizer, AstraZeneca, Big Pharma, emerging markets
Why AstraZeneca’s Respiratory Segment Is a Key Growth Platform
Market Realist
Mon, 11/14/16 - 10:44 pm
Tags:
AstraZeneca, Symbicort, Pulmicort, Tudorza, Eklira, Duaklir, Almirall
The Performance of AstraZeneca’s Growth Platforms in 3Q16
Market Realist
Mon, 11/14/16 - 10:20 am
Tags:
AstraZeneca, earnings
Inside AstraZeneca’s Revenue Fall in 3Q16
Market Realist
Sat, 11/12/16 - 09:06 am
Tags:
AstraZeneca, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.